Aducanumab: A Deep Dive into BIIB037 and its Impact A medication, initially known as BIIB037, constitutes a complex effort to address mild Alzheimer's illness. Created by Biogen, aducanumab functions by clearing https://www.targetmol.com/compound/aducanumab